Current status of drug screening and disease modelling in human pluripotent stem cells. (2013)
Attributed to:
Developing scalable and standardised manufacturing methods for human pluripotent stem cells
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/bies.201200053
PubMed Identifier: 22886688
Publication URI: http://europepmc.org/abstract/MED/22886688
Type: Journal Article/Review
Volume: 35
Parent Publication: BioEssays : news and reviews in molecular, cellular and developmental biology
Issue: 3
ISSN: 0265-9247